Qiagen N.V. (QGEN)
After hours:
| Previous close | 42.24 |
| Open | 42.92 |
| Bid | 43.41 x 900 |
| Ask | 44.53 x 1800 |
| Day's range | 42.87 - 44.14 |
| 52-week range | 34.74 - 47.32 |
| Volume | |
| Avg. volume | 1,105,590 |
| Market cap | 9.748B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 28.91 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.28 (2.94%) |
| Ex-dividend date | 30 Jan 2024 |
| 1y target est | N/A |
- GlobeNewswire
QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
Partnership with University of Montana drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains // QIAGEN provides instruments, kits and training for building the first Indigenous-owned DNA database and identifying African American human remains // Collaboration underlines QIAGEN’s leading position in the use of next-generation sequencing for forensic applications and human identificationMissoula, Montana, and Venlo, the Ne
- GlobeNewswire
QIAGEN N.V. to release results for Q2 2024 and hold webcast
Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024. Press release date / time: Wednesday, July 31, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, August 1, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. Three options for joining the conference call Register for call back connection
- GlobeNewswire
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
American Academy of Pediatrics in the United States now recommends IGRA tests like QuantiFERON-TB Gold Plus to screen at-risk children of all ages // New recommendation joins trend of U.S. tuberculosis control guidelines that emphasize use of modern blood-based tests to combat the spread of potentially deadly bacterial infectionGermantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes ne
